Senior US State Department official Allison Hooker and trade negotiators arrive in India to strengthen economic ties, discuss tariffs, and foster AI and space collaboration. Key meetings scheduled in New Delhi and Bengaluru.
India and Russia deepen strategic ties, signing agreements in trade, energy, and tech, aiming for $100 billion trade by 2030. Can this offset US tariff pressures?
Delhi High Court rejects Novo Nordisk's plea for interim injunction against Dr Reddy's Labs over semaglutide. Court cites 'evergreening', allows DRL to export. Key ruling for diabetes drug market.
A recent Delhi High Court order in the Novo Nordisk vs Dr Reddy's case highlights the complexities of Indian patent litigation. We examine the system's challenges and the push for specialized IP courts.
Anna Haakenson's viral Instagram post details 9 cultural contrasts between India and the US after a 2.5-month family trip. Discover the insights sparking global discussion.
As Putin visits India, the world watches how New Delhi will balance discounted Russian oil, defence needs, and US pressure. Will India secure its autonomy or face new sanctions?
Russian President Vladimir Putin aims to elevate cooperation with India to a new level during his Dec 4-5 visit. Defence deals like S-400, Su-57 jets & nuclear energy pacts to dominate talks.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
Eli Lilly reduces Zepbound's starting price to $299 monthly, intensifying its price war with Novo Nordisk's Ozempic and Wegovy. New discounts aim to expand access to blockbuster weight-loss drugs.
India's tourism sector sees a strong recovery, with the US, UK, and Canada among the top contributors. Discover the full list and key insights from the latest 2024-25 data.
Novo Nordisk and Eli Lilly develop daily oral weight loss pills with 10-16% average weight loss in trials. Pending FDA approval, these could replace injections.
IMF's latest assessment reveals India's strong economic outlook with 6.6% growth forecast. Discover how prudent policies and structural reforms drive sustained growth and reduce poverty.
Discover 10 breathtaking Indian destinations that offer European winter charm without international travel. Perfect winter escapes with snow, architecture & alpine vibes.
India becomes OpenAI's second-largest market as American firms invest billions. Discover how India's 900M internet users are shaping the future of artificial intelligence.
Discover the top 6 lifestyle diseases affecting Indians, their causes, symptoms, and preventive measures. Learn how to protect your health today!
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.
Novo Nordisk reduces Wegovy price by 37% in India, intensifying the weight loss drug war with Eli Lilly's Mounjaro. Discover the new costs and market impact.
Novo Nordisk reduces its weight loss drug Wegovy's price by 37% in India, intensifying competition with Eli Lilly's Mounjaro. Get the latest details on the new pricing and market dynamics.
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
India's festive season hiring rises 17% with gig roles surging 25% according to Adecco India report. Discover how temporary jobs are reshaping employment trends.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Prime Minister Narendra Modi announces massive ₹10,372 crore investment in India's AI ecosystem, positioning the nation as global artificial intelligence leader with focus on computing infrastructure and startup innovation.
Toyota, Honda, and Suzuki lead Japanese automakers in massive India expansion, creating thousands of jobs and challenging China's manufacturing dominance with unprecedented ₹11,000 crore investment.
Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.
Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.
OpenAI makes ChatGPT available for free to Indian users through Microsoft's Bing integration. Discover the benefits, limitations, and how to access this revolutionary AI tool.